TY - JOUR
KW - Anxiety Disorders/diagnosis/epidemiology/psychology
KW - Comorbidity
KW - Depressive Disorder/diagnosis/epidemiology/psychology
KW - Diagnostic and Statistical Manual of Mental Disorders
KW - Health Status
KW - Humans
KW - International Classification of Diseases
KW - Personality Inventory/statistics & numerical data
KW - Portugal/epidemiology
KW - Primary Health Care/methods
KW - Psychiatric Status Rating Scales
KW - Psychometrics
KW - Questionnaires
KW - Reproducibility of Results
KW - Sensitivity and Specificity
KW - Severity of Illness Index
KW - Sex Factors
KW - Somatoform Disorders/diagnosis/epidemiology/psychology
KW - Translating
AU - C. Fabiao
AU - M. C. Silva
AU - A. Barbosa
AU - M. Fleming
AU - W. Rief
A1 - 
AB - BACKGROUND: To investigate the validity and stability of a Portuguese version for the Screening for Somatoform Symptoms-2 (SOMS-2) in primary care (PC) settings. METHODS: An adapted version of the SOMS-2 was filled in by persons attending a PC unit. All medically unexplained symptoms were further ascertained in a clinical interview and by contacting the patient's physicians and examining medical records, attaining a final clinical symptom evaluation (FCSE). An interview yielded the diagnosis of Clinical Somatization (CS) and the diagnosis of current depressive and anxiety disorders. RESULTS: From the eligible subjects, 167 agreed to participate and 34.1% of them were diagnosed with somatization. The correlation between the number of self-reported and FCSE symptoms was 0.63. After excluding symptoms with low frequency, low discriminative power and not correlated with the overall scale, 29 were retained in the final version. A cut-off of 4 symptoms gave a sensitivity of 86.0% and a specificity of 95.5% on the FCSE and 56.1% and 93.6% at self-report. Stability in the number of symptoms after 6 months was good (k = 0.57). CONCLUSIONS: The 29 symptoms version of the SOMS-2 with a cut-off of 4 showed a high specificity and sensitivity, being reliable as a referral tool for further specialized diagnosis.
BT - BMC psychiatry
C5 - Medically Unexplained Symptoms
CY - England
DO - 10.1186/1471-244X-10-34
JF - BMC psychiatry
N2 - BACKGROUND: To investigate the validity and stability of a Portuguese version for the Screening for Somatoform Symptoms-2 (SOMS-2) in primary care (PC) settings. METHODS: An adapted version of the SOMS-2 was filled in by persons attending a PC unit. All medically unexplained symptoms were further ascertained in a clinical interview and by contacting the patient's physicians and examining medical records, attaining a final clinical symptom evaluation (FCSE). An interview yielded the diagnosis of Clinical Somatization (CS) and the diagnosis of current depressive and anxiety disorders. RESULTS: From the eligible subjects, 167 agreed to participate and 34.1% of them were diagnosed with somatization. The correlation between the number of self-reported and FCSE symptoms was 0.63. After excluding symptoms with low frequency, low discriminative power and not correlated with the overall scale, 29 were retained in the final version. A cut-off of 4 symptoms gave a sensitivity of 86.0% and a specificity of 95.5% on the FCSE and 56.1% and 93.6% at self-report. Stability in the number of symptoms after 6 months was good (k = 0.57). CONCLUSIONS: The 29 symptoms version of the SOMS-2 with a cut-off of 4 showed a high specificity and sensitivity, being reliable as a referral tool for further specialized diagnosis.
PP - England
PY - 2010
SN - 1471-244X; 1471-244X
SP - 34
T1 - Assessing medically unexplained symptoms: evaluation of a shortened version of the SOMS for use in primary care
T2 - BMC psychiatry
TI - Assessing medically unexplained symptoms: evaluation of a shortened version of the SOMS for use in primary care
U1 - Medically Unexplained Symptoms
U2 - 20478053
U3 - 10.1186/1471-244X-10-34
VL - 10
VO - 1471-244X; 1471-244X
Y1 - 2010
ER -